ArticleFrontiers in oncology2019

A Dose Escalation Study of Trientine Plus Carboplatin and Pegylated Liposomal Doxorubicin in Women With a First Relapse of Epithelial Ovarian, Tubal, and Peritoneal Cancer Within 12 Months After Platinum-Based Chemotherapy.

Yu-Fang Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.